SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
暂无分享,去创建一个
[1] H. Ge,et al. Apatinib ameliorates doxorubicin-induced migration and cancer stemness of osteosarcoma cells by inhibiting Sox2 via STAT3 signalling , 2019, Journal of orthopaedic translation.
[2] P. Zhou,et al. Autophagy plays an important role in stemness mediation and the novel dual function of EIG121 in both autophagy and stemness regulation of endometrial carcinoma JEC cells. , 2017, International journal of oncology.
[3] A. Amadori,et al. Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells , 2017, Cell Death & Disease.
[4] H. Onda,et al. PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma , 2017, Scientific Reports.
[5] Yang Ke,et al. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma , 2017, Journal of Experimental & Clinical Cancer Research.
[6] Jai-Sing Yang,et al. Epigallocatechin gallate sensitizes cisplatin‐resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling , 2017, Environmental toxicology.
[7] P. Picci,et al. Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight? , 2017, Future oncology.
[8] Hongwei Liang,et al. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy , 2017, Cell Death & Disease.
[9] Yunjiao Zhang,et al. Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells. , 2016, Biomaterials.
[10] Min Wang,et al. Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer , 2016, Tumor Biology.
[11] R. Clarke,et al. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling , 2016, Oncotarget.
[12] Wan-chun Wang,et al. Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1 , 2016, Tumor Biology.
[13] M. Ghanei,et al. Overexpression of the non-coding SOX2OT variants 4 and 7 in lung tumors suggests an oncogenic role in lung cancer , 2016, Tumor Biology.
[14] M. Ghanei,et al. Identification of new SOX2OT transcript variants highly expressed in human cancer cell lines and down regulated in stem cell differentiation , 2016, Molecular Biology Reports.
[15] Y. Morine,et al. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation , 2016, Journal of gastroenterology and hepatology.
[16] Jincheng Wang,et al. The survivin suppressant YM155 reverses doxorubicin resistance in osteosarcoma. , 2015, International journal of clinical and experimental medicine.
[17] Jianqin Sun,et al. EGCG Attenuates Uric Acid-Induced Inflammatory and Oxidative Stress Responses by Medicating the NOTCH Pathway , 2015, Oxidative medicine and cellular longevity.
[18] R. Gemeinhart,et al. Developing nanocrystals for cancer treatment. , 2015, Nanomedicine.
[19] Jun Wang,et al. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro , 2015, Tumor Biology.
[20] M. Pichler,et al. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells , 2015, BMC Complementary and Alternative Medicine.
[21] S. Mowla,et al. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis , 2015, Front. Genet..
[22] Sun-Hee Kim,et al. Sensitization of Chemo-Resistant Human Chronic Myeloid Leukemia Stem-Like Cells to Hsp90 Inhibitor by SIRT1 Inhibition , 2015, International journal of biological sciences.
[23] Yulei N. Wang,et al. EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells. , 2015, Journal of pharmacological sciences.
[24] Qi-rong Wang,et al. Green Tea Polyphenols Protects Cochlear Hair Cells from Ototoxicity by Inhibiting Notch Signalling , 2015, Neurochemical Research.
[25] J. Vadgama,et al. Sensitization to docetaxel in prostate cancer cells by green tea and quercetin. , 2015, The Journal of nutritional biochemistry.
[26] Xiaoming Shi,et al. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. , 2015, International journal of clinical and experimental pathology.
[27] Xinchao Zhang,et al. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells , 2015, International journal of nanomedicine.
[28] Xiaojie He,et al. Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate , 2014, World Journal of Surgical Oncology.
[29] Eda Acikgoz,et al. Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol , 2014, International journal of molecular medicine.
[30] M. Askarian-Amiri,et al. Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer , 2014, PloS one.
[31] X. Cen,et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. , 2014, Biochemical pharmacology.
[32] G. Zhang,et al. Autophagy Inhibition Contributes to the Synergistic Interaction between EGCG and Doxorubicin to Kill the Hepatoma Hep3B Cells , 2014, PloS one.
[33] G. Ottaviani,et al. Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents , 2013, Cancer.
[34] S. H. Lee,et al. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway. , 2013, European journal of cancer.
[35] Heiying Jin,et al. Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling , 2013, OncoTargets and therapy.
[36] C. Hayward,et al. Mutations in SOX2 cause anophthalmia , 2003, Nature Genetics.
[37] M. Baiocchi,et al. How to Assess Drug Resistance in Cancer Stem Cells. , 2018, Methods in molecular biology.
[38] R. Wu,et al. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells. , 2017, Biochemical and biophysical research communications.
[39] M. Esmaeili. Combination of siRNA-directed gene silencing with epigallocatechin-3-gallate (EGCG) reverses drug resistance in human breast cancer cells , 2016, Journal of chemical biology.
[40] Zhengshi Zhang,et al. (-)-Epigallocatechin-3-gallate inhibits osteosarcoma cell invasiveness by inhibiting the MEK/ERK signaling pathway in human osteosarcoma cells. , 2015, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[41] D. Tang,et al. HMGB1 promotes drug resistance in osteosarcoma. , 2012, Cancer research.